XENE logo

XENE
Xenon Pharmaceuticals Inc

2,737
Mkt Cap
$5.42B
Volume
667,703.00
52W High
$63.95
52W Low
$26.74
PE Ratio
-13.04
XENE Fundamentals
Price
$57.65
Prev Close
$56.84
Open
$56.69
50D MA
$47.99
Beta
0.84
Avg. Volume
2.28M
EPS (Annual)
-$4.36
P/B
7.82
Rev/Employee
$20,270.27
$3,011.21
Loading...
Loading...
News
all
press releases
Xenon Pharmaceuticals (NASDAQ:XENE) Sees Strong Trading Volume - What's Next?
Xenon Pharmaceuticals (NASDAQ:XENE) Sees Large Volume Increase - Should You Buy...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Aberdeen Group plc Increases Stock Position in Xenon Pharmaceuticals Inc. $XENE
Aberdeen Group plc raised its stake in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) by 29.6% in the 4th quarter, according to its most recent 13F filing with the Securities...
MarketBeat·3d ago
News Placeholder
Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE)
Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) was the target of unusually large options trading activity on Wednesday. Traders bought 4,063 put options on the stock. This represents an...
MarketBeat·6d ago
News Placeholder
Assenagon Asset Management S.A. Invests $5.34 Million in Xenon Pharmaceuticals Inc. $XENE
Assenagon Asset Management S.A. acquired a new stake in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) in the fourth quarter, according to the company in its most recent Form 13F...
MarketBeat·10d ago
News Placeholder
Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price Crosses Above Fifty Day Moving Average - Time to Sell?
Xenon Pharmaceuticals (NASDAQ:XENE) Share Price Crosses Above 50-Day Moving Average - Should You Sell...
MarketBeat·11d ago
News Placeholder
Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know
Key PointsThe chief medical officer of Xenon Pharmaceuticals directly sold 1,410 common shares for a transaction value of $78,000 on March 13, 2026...
Nasdaq News: Markets·11d ago
News Placeholder
Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why
XENE shares gain 20% in 3 months as positive phase III data for epilepsy drug azetukalner and pipeline progress boost outlook and investor confidence.
Zacks·19d ago
News Placeholder
Investors Buy High Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE)
Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) was the target of some unusual options trading activity on Wednesday. Traders purchased 4,063 put options on the stock. This represents an...
MarketBeat·20d ago
News Placeholder
Jain Global LLC Takes Position in Xenon Pharmaceuticals Inc. $XENE
Jain Global LLC bought a new stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 252,379...
MarketBeat·22d ago
News Placeholder
Holocene Advisors LP Acquires 167,078 Shares of Xenon Pharmaceuticals Inc. $XENE
Holocene Advisors LP boosted its holdings in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) by 9.2% in the third quarter, according to the company in its most recent 13F filing with...
MarketBeat·22d ago
<
1
2
...
>

Latest XENE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.